Imaging Endpoints   Report issue

For profit Phase 2
Founded: Scottsdale AZ United States (2009)

Organization Overview

First Clinical Trial
2017
NCT03410030
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Imaging Endpoints